Studies on beta-D-xylofuranosyl-6-thioguanine in mice.
D000225:Adenine / Q000096:biosynthesis; D000818:Animals; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002460:Cell Line; D002845:Chromatography; D004273:DNA, Neoplasm / Q000378:metabolism; D005260:Female; D005663:Furans; D005998:Glycine / Q000096:biosynthesis; D006147:Guanine / Q000652:urine; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009963:Orotic Acid / Q000096:biosynthesis; D014176:Protein Biosynthesis; D011687:Purines / Q000096:biosynthesis; D011743:Pyrimidines / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000378:metabolism; D013460:Sulfur Isotopes; D013866:Thioguanine / Q000627:therapeutic use*; D014994:Xylose
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D005663:Furans; D007166:Immunosuppressive Agents; D011687:Purines; D011743:Pyrimidines; D012334:RNA, Neoplasm; D013460:Sulfur Isotopes; D006147:Guanine; D009963:Orotic Acid; D014994:Xylose; D013866:Thioguanine; D000225:Adenine; D005998:Glycine